Director appointment - Dr Graham Cooley

Gelion PLC

06 January 2025

 

6 January 2025

Gelion plc

("Gelion" or "the Company")

Director appointment - Dr Graham Cooley

Further to the announcement made on 18 December 2024, the Board of Gelion plc, the global energy storage innovator, is pleased to announce the appointment of Dr Graham Cooley, as Non-Executive Director of the Company with immediate effect. Dr Cooley's appointment strengthens the Company's capabilities and corporate governance for the next stage of its growth.

Dr Graham Cooley brings a wealth of relevant experience and knowledge to the Gelion Board through his background in the power, energy storage and hydrogen sectors over more than 35 years. He was previously Business Development Manager at National Power plc, the UK's largest power generator, and CEO of ITM Power plc, the first hydrogen related company quoted on AIM. Dr Cooley has been involved in a wide range of corporate transactions, including ones that have raised over £600m for UK cleantech SMEs. He also has a track record of forging industrial partnerships and entering new markets. He has been an active investor in AIM UK cleantech companies for over a decade and holds a PhD in Materials Physics, an MBA and has several fellowship appointments.

Dr Cooley has been appointed as a member of the Company's Audit Committee and Remuneration Committee.

Steve Mahon, Chairman of Gelion, commented: "I am delighted to be welcoming Graham to the Gelion board. He brings extensive and very relevant experience which will prove invaluable as we continue to progress toward commercialisation of our battery technologies."

John Wood, Chief Executive of Gelion, commented: "Graham brings his exemplary full scope entrepreneurial perspective to the Gelion board, with the combination of the depth of personal understanding he has of delivering successful commercialisation and value development running innovation companies, along with his experience with investment markets. Welcome Graham!"

Further disclosures pursuant to Rule 17 and Schedule Two, paragraph (g) of the AIM Rules for Companies:

Dr Graham Edward Cooley

The following information regarding the appointment of Dr Graham Edward Cooley, aged 61, is disclosed under Schedule 2(g) of the AIM Rules for Companies:

Current directorships and/or partnerships	Past directorships and/or partnerships (within the last five years)
Light Science Technologies Holdings plc	ITM Power plc
Brigantia Capital Ltd	H2 Green Ltd
Cadent Gas Limited	ITM Power UK Limited (formerly ITM Power (Trading) Limited)
Cap-XX Limited	ITM Power Pty Limited
Quadgas Holdco Limited	ITM Linde Electrolysis GmbH
Quadgas Investments Bidco Limited	ITM Power ApS
Quadgas Midco Limited	ITM Power Service GmbH
Quadgas Pledgeco Limited	ITM Service GmbH
Yelooc Limited	ITM Power (Shelfco) Limited
LSTH Trustee Limited	ITM Power (Research) Limited
Light Science Technologies Ltd	Motive Fuels Limited
Tomtech (UK) Limited	Nanosun Limited
LSTH IFB Limited	Orkney Hydrogen Trading Ltd
UK Circuits and Electronics Solutions Limited	Renewable UK Association
UK Circuits and Electronics Solutions Holdings Limited
Quadgas Holdings Topco Limited (UK)
Quadgas Holdings Topco Limited (Jersey)

Nanosun Limited entered into director led administration on 6 February 2024 and on the same date, a pre-pack sale of the business and certain assets was completed.

Dr Cooley currently holds 666,666 Ordinary Shares, representing 0.45% of the Company's issued Ordinary Share capital.

CONTACTS

Gelion plc John Wood, CEO Amit Gupta, CFO	via Alma
Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)	[phone]
Neil McDonald / Seamus Fricker / Adam Rae (Corporate Finance) Louise Talbot (Sales)
Oberon Capital (Joint Broker)	[phone]
Nick Lovering, Mike Seabrook, Adam Pollock
Alma Strategic Communications (Financial PR Adviser) Justine James / Hannah Campbell / Will Ellis Hancock	[phone] [e-mail]

About Gelion

Gelion ("gel: ion") is a global energy storage innovator, supporting the transition to a more sustainable economy by commercialising two globally important next generation technologies: Lithium-Sulfur (LiS) and Zinc-based (Zn) hybrid cells to electrify mobile and stationary applications. Gelion plc (the Group) is listed on the London Stock Exchange's Alternative Investment Market and wholly owns Australia based Gelion Technologies Pty Ltd and UK based OXLiD Ltd. Gelion is designing and delivering innovative battery technologies and integrated systems solutions to enable that transition and return value for its customers and investors.

 

END